Guided Therapeutics, Inc. (GTHP)

Guided Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	8	8	10	8	3	0
Market Cap Growth	-42.32%	-19.51%	25.69%	140.28%	635.26%	-97.19%
Enterprise Value	10	9	10	10	7	6
PE Ratio	-	-2.25	-1.96	-2.08	-2.42	-0.13
PS Ratio	97.72	80.09	750.12	95.79	31.66	12.20
PB Ratio	-1.63	-2.06	-3.38	-1.42	-0.30	-0.03
P/FCF Ratio	-4.86	-4.50	-6.46	-4.83	-1.72	-0.54
P/OCF Ratio	-4.86	-4.50	-6.60	-4.87	-1.72	-0.54
EV/Sales Ratio	116.98	95.06	746.27	123.64	73.06	154.42
EV/EBITDA Ratio	-2.82	-2.76	-2.99	-5.65	-9.54	-6.40
EV/EBIT Ratio	-2.73	-2.69	-2.92	-5.40	-	-6.25
EV/FCF Ratio	-6.03	-5.34	-6.43	-6.24	-3.97	-6.90
Debt / Equity Ratio	-0.47	-0.50	-0.78	-0.53	-0.41	-0.36
Debt / EBITDA Ratio	-0.70	-0.61	-0.70	-1.64	-5.64	-6.93
Debt / FCF Ratio	-1.50	-1.18	-1.50	-1.81	-2.35	-7.47
Quick Ratio	0.08	0.12	0.48	0.12	0.02	0.07
Current Ratio	0.23	0.29	0.62	0.29	0.10	0.08
Asset Turnover	0.04	0.06	0.00	0.04	0.08	0.03
Interest Coverage	-5.61	-12.44	-5.73	-2.05	-1.00	-0.66
Return on Equity (ROE)	75.32%	91.67%	172.46%	68.45%	12.30%	19.96%
Return on Assets (ROA)	-202.28%	-209.05%	-147.71%	-182.70%	-98.89%	-286.53%
Return on Capital (ROIC)	149.50%	197.77%	537.58%	92.77%	16.31%	8.58%
Earnings Yield	-37.71%	-44.45%	-50.99%	-48.04%	-41.34%	-769.87%
FCF Yield	-16.81%	-22.25%	-15.47%	-20.70%	-58.10%	-183.53%
Buyback Yield / Dilution	-11.06%	-57.30%	-142.99%	-24.24%	-226.08%	94.94%
Total Shareholder Return	-11.06%	-57.30%	-142.99%	-24.24%	-226.08%	94.94%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.